591 reports of this reaction
1.9% of all ROPINIROLE reports
#10 most reported adverse reaction
DYSPNOEA is the #10 most commonly reported adverse reaction for ROPINIROLE, manufactured by Accord Healthcare Inc.. There are 591 FDA adverse event reports linking ROPINIROLE to DYSPNOEA. This represents approximately 1.9% of all 31,217 adverse event reports for this drug.
Patients taking ROPINIROLE who experience dyspnoea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DYSPNOEA is a less commonly reported adverse event for ROPINIROLE, but still significant enough to appear in the safety profile.
In addition to dyspnoea, the following adverse reactions have been reported for ROPINIROLE:
The following drugs have also been linked to dyspnoea in FDA adverse event reports:
DYSPNOEA has been reported as an adverse event in 591 FDA reports for ROPINIROLE. This does not prove causation, but indicates an association observed in post-market surveillance data.
DYSPNOEA accounts for approximately 1.9% of all adverse event reports for ROPINIROLE, making it a notable side effect.
If you experience dyspnoea while taking ROPINIROLE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.